Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
PURPOSE: Bladder cancer recurrence occurs in 40% of patients following radical cystectomy (RC) and pelvic lymphadenectomy (PLND). Although recurrence can be reduced with adjuvant chemotherapy, the toxicity and low response rates of this treatment restrict its use to patients at highest risk. We dev...
Autors principals: | Catto, J, Abbod, M, Linkens, D, Larré, S, Rosario, D, Hamdy, F |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2009
|
Ítems similars
-
Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle‐Invasive Bladder Cancer in the United States
per: Bernard Bright Davies‐Teye, et al.
Publicat: (2025-02-01) -
Radical cystectomy for bladder urothelial carcinoma with aggressive variant histology
per: Vahid Mehrnoush, et al.
Publicat: (2022-09-01) -
The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy
per: Jin Hyuck Kim, et al.
Publicat: (2023-03-01) -
Resolution of hypercalcemia of malignancy following radical cystectomy in a patient with paraneoplastic syndrome associated with urothelial carcinoma of the bladder
per: Alfredo Harb-De La Rosa, et al.
Publicat: (2015-01-01) -
Comparative study of intelligent models for the prediction of bladder cancer progression.
per: Abbod, M, et al.
Publicat: (2006)